The Enterprise Value as of September 2024 (TTM) for Palisade Bio, Inc. (PALI) is -6131584.00

According to Palisade Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -6131584.00. This represents a change of -15.05% compared to the average of -7217987.59 of the last 4 quarters.

Palisade Bio, Inc. (PALI) Historical Enterprise Value (quarterly & annually)

How has PALI Enterprise Value performed in the past?

The mean historical Enterprise Value of Palisade Bio, Inc. over the last ten years is 3.65B. The current -6131584.00 Enterprise Value has changed -116.79% with respect to the historical average. Over the past ten years (40 quarters), PALI's Enterprise Value was at its highest in in the September 2014 quarter at 25.79B. The Enterprise Value was at its lowest in in the September 2023 quarter at -10542838.77.

Palisade Bio, Inc. (PALI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Palisade Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Palisade Bio, Inc. (PALI) Average Enterprise Value

How has PALI Enterprise Value performed in the past?

The current Enterprise Value of Palisade Bio, Inc. (PALI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Palisade Bio, Inc. (PALI) Enterprise Value vs. Peers

How is PALI’s Enterprise Value compared to its peers?

Palisade Bio, Inc.’s Enterprise Value is less than Zura Bio Limited (41.78M), less than Altamira Therapeutics Ltd. (889.79K), less than Immix Biopharma, Inc. (27.90M), less than Enveric Biosciences, Inc. (956.52K), less than eFFECTOR Therapeutics, Inc. (3.86M), less than Virios Therapeutics, Inc. (2.47M), less than Navidea Biopharmaceuticals, Inc. (-2504975.00), less than ZyVersa Therapeutics, Inc. (2.42M), less than Phio Pharmaceuticals Corp. (-1900743.00), less than NovaBay Pharmaceuticals, Inc. (3.62M), less than Unicycive Therapeutics, Inc. (40.53M), less than Apexigen, Inc. (205.32K),

Build a custom stock screener for Palisade Bio, Inc. (PALI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Palisade Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Palisade Bio, Inc. (PALI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Palisade Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.